References
- Katz TM, Miller JH, Hebert AA. Insect repellents: historical perspectives and new developments. J Am Acad Dermatol. 2008;58:865–871.
- Fradin MS. Mosquitoes and mosquito repellents: a clinician’s guide. Ann Int Med. 1998;128:931–940.
- Staub D, Debrunner M, Amsler L, Steffen R. Effectiveness of a repellent containing DEET and EBAAP for preventing tick bites. Wilderness Environ Med. 2002;13:12–20.
- Koren G, Matsui D, Bailey B. DEET-based insect repellents: safety implications for children and pregnant and lactating women. Can Med Assoc J. 2003;169:209–212.
- Qiu H, Jun HW, Tao J. Pharmacokinetics of insect repellent N,N-diethyl-m-toluamide in beagle dogs following intravenous and topical routes of administration. J Pharm Sci. 1997;86:514–516.
- Robbins PJ, Cherniak MG. Review of the biodistribution and toxicity of the insect repellent N,N-diethyl-m-toluamide (DEET). J Toxicol Environ Health. 1986;18:503–525.
- Abdel-Rahman A, Abou-Donia SM, El-Masry EM, Shetty AK, Abou-Donia MB. Stress and combined exposure to low doses of pyridostigmine bromide, DEET, and permethrin produce neurochemical and neuropathological alterations in cerebral cortex, hippocampus, and cerebellum. J Toxicol Environ Health A. 2004;67:163–192.
- Abdel-Rahman A, Dechkovskaia AM, Goldstein LB, Bullman SH, Khan W, El-Masry EM, Abou-Donia MB. Neurologivcal deficits induced by malathion, DEET, and permethrin, alone or in combination in adult rats. J Toxicol Environ Health A. 2004;67:331–356.
- Naucke TJ, Kröpke R, Benner G, Schulz J, Wittern KP, Rose A, Kro¨ckel U, Gru¨newald HW. Field evaluation of the efficacy of proprietary repellent formulations with IR3535 and picaridin against Aedes aegypti. Parastol Res. 2007;101:169–177.
- Zhu J, Zeng X, O’Neal M, Schultz G, Tucker B, Coats J, Bartholomay L, Xue RD. Mosquito larvicidal activity of botanical-based mosquito repellents. J Am Mosq Control Assoc. 2008;24:161–168.
- Chatelain E, Gabard B, Surber C. Skin penetration and sun protection factor of five UV filters: effect of the vehicle. Skin Pharmacol Appl Skin Physiol. 2003;16:28–35.
- Felton LA, Wiley CJ, Godwin DA. Influence of cyclodextrin complexation on the in vivo photoprotective effects of oxybenzone. Drug Dev Ind Pharm. 2004;30:95–102.
- Hayden CJ, Roberts MS, Benson HAE. Systemic absorption of sunscreen after topical application. Lancet. 1997;350:863–864.
- Pont AR, Charron AR, Brand RM. Active ingredients act as topical penetration enhancers for the herbicide 2,4-dichlorophenoxyacetic acid. Toxicol Appl Pharmacol. 2004;195:348–354.
- Montemarano AD, Gupta RK, Burge JR, Klein K. Insect repellents and the efficacy of sunscreen. Lancet. 1997;349:1670–1671.
- Murphy ME, Montemarano AD, Debboun M, Gupta R. The effect of sunscreen on the efficacy of insect repellent: a clinical trial. J Am Acad Dermatol. 2000;43:219–222.
- Gu X, Kasichayanula S, Fediuk DJ, Burczynski FJ. In-vitro permeation of the insect repellent N,N-diethyl-m-toluamide (DEET) and the sunscreen oxybenzone. J Pharm Pharmacol. 2004;56:621–628.
- Gu X, Wang T, Collins DM, Kasichayanula S, Burczynski FJ. In vitro evaluation of concurrent use of commercially available insect repellent and sunscreen preparations. Br J Dermatol. 2005;152:1263–1267.
- Wang T, Gu X. Permeation of repellent DEET and sunscreen oxybenzone across human skin. J Pharm Pharm Sci. 2007;10:17–25.
- Kasichayanula S, House JD, Wang T, Gu X. Percutaneous characterization of the insect repellent DEET and the sunscreen oxybenzone from topical skin application. Toxicol App Pharmacol. 2007;223:187–194.
- Crank J. The mathematics of diffusion. 2nd ed. New York: Oxford University Press; 1975.
- Feldmann RJ, Maibach HI. Regional variation in percutaneous penetration of 14C cortisol in man. J Invest Dermatol. 1967;48:181–183.
- Scheuplein RJ. The physiology and pathophysiology of the skin. In: ed. Jarrett A. Site variations in diffusion and permeability. New York: Academic Press; 1978:1731–1752.
- Stamatialis DF, Rolevink HHM Koops GH. Controlled transport of timolol maleate through artificial membranes under passive and iontophoretic conditions. J Control Release. 2002;81:335–345.
- Dias M, Farinha A, Faustino E, Hadgraft J, Pais J, Toscano C. Topical delivery of caffeine from some commercial formulations. Int J Pharm. 1999;182:41–47.
- Jiang R, Benson HA, Cross SE, Roberts MS. In vitro human epidermal and polyethylene membrane penetration and retention of the sunscreen benzophenone-3 from a range of solvents. Pharm Res. 1998;15:1863–1868.
- Wissing SA, Müller RH. Solid lipid nanoparticles as carrier for sunscreens: in vitro release and in vivo skin penetration. J Control Release. 2002;81:225–233.